Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Assets (2016 - 2025)

Tandem Diabetes Care's Assets history spans 13 years, with the latest figure at $881.1 million for Q4 2025.

  • For Q4 2025, Assets fell 8.94% year-over-year to $881.1 million; the TTM value through Dec 2025 reached $881.1 million, down 8.94%, while the annual FY2025 figure was $881.1 million, 8.94% down from the prior year.
  • Assets reached $881.1 million in Q4 2025 per TNDM's latest filing, up from $874.7 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $1.1 billion in Q4 2022 to a low of $754.3 million in Q1 2021.
  • Average Assets over 5 years is $930.4 million, with a median of $940.5 million recorded in 2023.
  • Peak YoY movement for Assets: soared 119.7% in 2021, then decreased 10.27% in 2023.
  • A 5-year view of Assets shows it stood at $905.1 million in 2021, then increased by 16.31% to $1.1 billion in 2022, then fell by 9.51% to $952.7 million in 2023, then rose by 1.57% to $967.7 million in 2024, then decreased by 8.94% to $881.1 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Assets are $881.1 million (Q4 2025), $874.7 million (Q3 2025), and $875.7 million (Q2 2025).